(Q73383699)
Statements
Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages (English)
C J Bruns
H Shinohara
M T Harbison
D W Davis
G Nelkin
J J Killion
D J McConkey